BREA, Calif., Dec. 22, 2021 /PRNewswire/ — Envista Holdings Company (NYSE: NVST) (“Envista”) currently introduced it has entered into a definitive settlement to acquire Carestream Dental’s Intra-Oral Scanner (IOS) organization for $600 million. The transaction is matter to customary regulatory approvals and envisioned to near in Q2 2022.
The acquisition of this business is in line with Envista’s extensive-time period technique to concentrate on the speediest escalating segments of the dental market and to build differentiated solutions by way of the digitalization of dental workflows. With predicted yearly sales of all around $60 million in 2021, this business enterprise is a large expansion, superior margin small business that is complementary to the two Envista’s Devices and Consumables section and the Specialty Products and Technologies section.
Envista Holdings Corporation CEO Amir Aghdaei mentioned, “Intra-oral scans are often the initial action in the electronic workflow and critical to a lot of substantial worth dental treatments which includes implants, prosthetics, and aligners. We are thrilled to incorporate a suite of earth-course intra-oral scanners and software program to our portfolio. This acquisition further permits our reason of partnering with dental specialists to enhance patients’ lives by digitizing, personalizing, and democratizing dental treatment.”
The transaction is issue to the satisfaction of sure customary closing problems, including the receipt of relevant regulatory approvals. The transaction is not issue to a funding situation or shareholder vote.
J.P. Morgan Securities LLC acted as monetary advisor and Kirkland & Ellis LLP acted as lawful advisor to Envista on the transaction.
Supplemental aspects about the transaction will be set forth in a Existing Report on Type 8-K to be submitted by Envista and accessible at www.sec.gov.
ABOUT ENVISTA
Envista is a world loved ones of far more than 30 reliable dental brand names, including KaVo, Kerr, Nobel Biocare, and Ormco, united by a shared reason: to lover with industry experts to make improvements to lives. Envista allows its shoppers provide the most effective doable patient care through market-main dental consumables, remedies, technology, and products and services. Our comprehensive portfolio, including dental implants and treatment method selections, orthodontics, and digital imaging technologies, handles an believed 90% of dentists’ scientific requirements for diagnosing, dealing with, and protecting against dental circumstances as nicely as enhancing the aesthetics of the human smile. With a basis comprised of the demonstrated Envista Organization Process (EBS) methodology, an expert management crew, and a potent society grounded in constant enhancement, dedication to innovation, and deep customer target, Envista is well geared up to satisfy the conclusion-to-close needs of dental gurus around the globe. Envista is a single of the premier world wide dental products businesses, with sizeable industry positions in some of the most interesting segments of the dental items field. For additional facts, make sure you stop by www.envistaco.com.
Ahead-Hunting STATEMENTS
Particular statements in this push release are “ahead-looking” statements inside the that means of the federal securities legislation. There are a range of significant components that could induce genuine effects, developments, and enterprise conclusions to vary materially from individuals proposed or indicated by these types of forward-wanting statements and you really should not area undue reliance on any this kind of forward-searching statements. These things include, among other items, the influence of the announcement of the transaction on the Company’s company relationships, functioning final results, share selling price or organization usually, the occurrence of any event or other conditions that could give increase to the termination of the obtain arrangement, the outcome of any authorized proceedings that may perhaps be instituted towards the Corporation similar to the transaction, the failure to fulfill any of the ailments to completion of the transaction, and the failure to recognize the anticipated rewards resulting from the transaction, the effect of the COVID-19 pandemic, including new variants of the virus, the tempo of restoration in the marketplaces in which we run, world wide provide chain disruptions and likely staffing shortages, the ailments in the U.S. and world wide financial state, the markets served by us and the financial marketplaces, the effects of our debt obligations on our operations and liquidity, developments and uncertainties in trade guidelines and laws, contractions or growth costs and cyclicality of marketplaces we serve, fluctuations in inventory of our distributors and consumers, reduction of a key distributor, our interactions with and the performance of our channel associates, competitors, our ability to produce and effectively current market new merchandise and expert services, the possible for improper perform by our workers, brokers or business partners, our compliance with relevant rules and laws (like polices relating to professional medical units and the well being care marketplace), the outcomes of our medical trials and perceptions thereof, penalties connected with any off-label marketing and advertising of our merchandise, modifications to our products that have to have new advertising and marketing clearances or authorizations, our skill to successfully tackle value reductions and other alterations in the wellbeing care business, our potential to successfully establish and consummate ideal acquisitions and strategic investments, our potential to combine the enterprises we receive and realize the anticipated added benefits of such acquisitions, contingent liabilities relating to acquisitions, investments and divestitures, considerable limits and/or likely liability based on tax implications of transactions with Danaher, security breaches or other disruptions of our information know-how systems or violations of information privacy legal guidelines, our means to adequately protect our intellectual home, the effects of our restructuring things to do on our means to grow, threats relating to forex exchange costs, adjustments in tax legal guidelines relevant to multinational firms, litigation and other contingent liabilities such as mental property and environmental, health and fitness and safety issues, hazards relating to item, support or program flaws, threats relating to product production, commodity charges and surcharges, our ability to alter buys and manufacturing capacity to reflect current market conditions, reliance on sole or limited sources of offer, the impression of regulation on demand for our solutions and solutions, labor matters, worldwide financial, political, authorized, compliance and organization factors, and disruptions relating to war, terrorism, common protests and civil unrest, male-designed and pure disasters, community wellness troubles and other functions. Further information with regards to the variables that could cause true effects to differ materially from these ahead-wanting statements is accessible in our SEC filings, including our Annual Report on Type 10-K for fiscal calendar year 2020 and our Quarterly experiences on Sort 10-Q. These ahead-seeking statements discuss only as of the date of this press launch and besides to the extent essential by applicable law, we do not presume any obligation to update or revise any ahead-looking statement, irrespective of whether as a outcome of new facts, long run occasions and developments or otherwise.
Speak to
Stephen Keller
Investor Relations
Envista Holdings Corporation
200 S. Kraemer Blvd., Making E
Brea, CA 92821
Telephone: (714) 817-7000
Fax: (714) 817-5450
Supply Envista Holdings Corporation
